You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Postmenopausal Women with Hormone Receptor-Positive Locally Advanced Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 13, 2022

A NIS of Alpelisib in Combination With Fulvestrant in

Not yet recruiting
  • Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
  • Alpelisib
  • Fulvestrant
  • (no location specified)
Aug 9, 2022

Breast Cancer Trial in Egypt

Completed
  • Breast Cancer
    • Alexandria, Egypt
    • +7 more
    Jan 24, 2022

    Metastatic Breast Cancer Trial in United States (Sorafenib, Letrozole)

    Terminated
    • Metastatic Breast Cancer
    • Washington, District of Columbia
    • +3 more
    Sep 21, 2021

    Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)

    Not yet recruiting
    • Breast Neoplasms
    • Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
    • +2 more
    Oct 23, 2023

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Ocala, Florida
      Ocala Oncology Center PL DBA Florida Cancer Affiliates
    Jul 19, 2023

    HER2-positive Breast Cancer, Advanced Breast Cancer Trial in Phoenix, Miami, Boston (Prolonged Overnight Fasting,

    Not yet recruiting
    • HER2-positive Breast Cancer
    • Advanced Breast Cancer
    • Prolonged Overnight Fasting
    • +2 more
    • Phoenix, Arizona
    • +2 more
    Nov 8, 2023

    Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

    Not yet recruiting
    • Advanced Solid Tumor
    • +8 more
    • (no location specified)
    Nov 13, 2023

    Hormone Receptor Positive Malignant Tumor of Breast Trial in United States (RAD140)

    Completed
    • Hormone Receptor Positive Malignant Neoplasm of Breast
    • New Haven, Connecticut
    • +4 more
    Aug 16, 2022

    HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

    Not yet recruiting
    • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
    • PERT-IJS plus trastuzumab, carboplatin and docetaxel
    • Perjeta plus trastuzumab, carboplatin and docetaxel
    • (no location specified)
    Sep 21, 2023

    CDK4/6 Inhibitors in Hormone Receptor-positive Advanced Breast

    Not yet recruiting
    • Breast Cancer
    • CDK4/6 inhibitor
    • Shanghai, Shanghai, China
      Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
    Apr 5, 2023

    Hormone Receptor Positive Breast Cancer Trial in Worldwide (Everolimus, Letrozole, Exemestane)

    Completed
    Has Results
    • Hormone Receptor Positive Breast Cancer
    • Birmingham, Alabama
    • +51 more
    Jan 12, 2022

    Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

    Not yet recruiting
    • Hormone Receptor-positive Breast Cancer
    • +2 more
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Oct 5, 2022

    Breast Cancer Trial (Inavolisib, Fulvestrant, Alpelisib)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Jan 30, 2023

    Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Oct 10, 2022

    Breast Cancer Trial in Tianjin (Dalpiciclib, Pyrotinib, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • Tianjin, China
      Tianjin Cancer Hospital
    Mar 28, 2023

    Breast Cancer Trial in Chuo-Ku, Kashiwa-Shi, Nagoya-Shi (Amcenestrant (SAR439859))

    Active, not recruiting
    • Breast Cancer
    • Amcenestrant (SAR439859)
    • Chuo-Ku, Japan
    • +2 more
    Nov 16, 2022

    Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

    Not yet recruiting
    • Hormone-receptor-positive Breast Cancer
    • +3 more
    • Aromatase inhibitor
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Apr 5, 2023

    Advanced ER+, HER2-Negative Breast Cancer Trial in Waltham (Elacestrant)

    Completed
    • Advanced ER+, HER2-Negative Breast Cancer
    • Waltham, Massachusetts
      Radius Pharmaceuticals, Inc.
    Aug 16, 2022

    HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

    Recruiting
    • HR+/HER2- Advanced Breast Cancer
    • Targeted Therapy
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Aug 1, 2023

    Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

    Recruiting
    • Locally Advanced or Unresectable Metastatic Breast Cancer
    • Stage IV Breast Cancer
    • Sacituzumab Govitecan-hziy
    • +3 more
    • Marietta, Georgia
    • +1 more
    Apr 21, 2023

    Invasive Breast Cancer Trial in Milwaukee (Cemiplimab, Paclitaxel, Carboplatin (not mandatory))

    Recruiting
    • Invasive Breast Cancer
    • Milwaukee, Wisconsin
      Froedtert Hospital & Medical College of Wisconsin
    Apr 1, 2022

    Breast Cancer Trial in Worldwide (ribociclib (LEE011), Exemestane, Everolimus (RAD001))

    Completed
    • Breast Cancer
    • ribociclib (LEE011)
    • +2 more
    • Fayetteville, Arkansas
    • +12 more
    Apr 8, 2021

    Blood and Tumor Samples From Advanced or Metastatic Estrogen

    Active, not recruiting
    • Advanced Breast Carcinoma
    • +8 more
    • Biopsy
    • +2 more
    • Scottsdale, Arizona
    • +2 more
    Jan 3, 2023

    Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston

    Completed
    Has Results
    • Breast Cancer Stage IV
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Oct 21, 2022